This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

Recurrent miscarriage: diabetes drug could ... An existing drug can be used to improve the womb for pregnancy, ... (08 Jan 2020)
Nerve Stimulation May Benefit Women with ... A treatment involving electrical nerve stimulation helped women ... (08 Jan 2020)
Cancer drugs could potentially treat COPD, ... New research from the University of Sheffield shows a certain ... (08 Jan 2020)
Tea drinkers live longer Drinking tea at least three times a week is linked with a longer ... (08 Jan 2020)

Both Lower Endoscopy and FOBT Found Effective in Colorectal Cancer Screening

The benefits of screening for colorectal cancer, regardless of approach, are made apparent in two New England Journal of Medicine studies.

The first study comprises almost 90,000 clinicians followed for 22 years. Relative to no self-reported endoscopy, those who underwent sigmoidoscopy had an approximately 40% reduction in colorectal cancer mortality; the reduction was even higher with colonoscopy (70%).


The second study examines 30-year outcomes in some 47,000 people randomized to usual care or to annual or biennial fecal occult-blood testing (FOBT) during two 6-year spans. Compared with usual care, the relative risk for colorectal cancer death was 0.68 for annual screening and 0.78 for biennial screening.

Editorialists warn against comparing endoscopy versus FOBT on the basis of these studies, since screening technologies have changed over the years and ongoing trials are addressing their comparative effectiveness.


NEMJ article




Connect with other Medical Professionals on fb in a closed facebook group


We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…